Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Cash from Financing Activities: 2009-2024

Historic Cash from Financing Activities for Cumberland Pharmaceuticals (CPIX) over the last 16 years, with Dec 2024 value amounting to $196,904.

  • Cumberland Pharmaceuticals' Cash from Financing Activities rose 27.93% to -$386,879 in Q3 2025 from the same period last year, while for Sep 2025 it was -$7.4 million, marking a year-over-year decrease of 8539.54%. This contributed to the annual value of $196,904 for FY2024, which is 102.65% up from last year.
  • As of FY2024, Cumberland Pharmaceuticals' Cash from Financing Activities stood at $196,904, which was up 102.65% from -$7.4 million recorded in FY2023.
  • In the past 5 years, Cumberland Pharmaceuticals' Cash from Financing Activities ranged from a high of $196,904 in FY2024 and a low of -$7.4 million during FY2023.
  • Moreover, its 3-year median value for Cash from Financing Activities was -$2.1 million (2022), whereas its average is -$3.1 million.
  • As far as peak fluctuations go, Cumberland Pharmaceuticals' Cash from Financing Activities tumbled by 260.10% in 2023, and later surged by 102.65% in 2024.
  • Yearly analysis of 5 years shows Cumberland Pharmaceuticals' Cash from Financing Activities stood at -$7.1 million in 2020, then soared by 50.06% to -$3.6 million in 2021, then skyrocketed by 41.98% to -$2.1 million in 2022, then crashed by 260.10% to -$7.4 million in 2023, then soared by 102.65% to $196,904 in 2024.